296 related articles for article (PubMed ID: 12177374)
1. Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease.
Delacourte A; Sergeant N; Champain D; Wattez A; Maurage CA; Lebert F; Pasquier F; David JP
Neurology; 2002 Aug; 59(3):398-407. PubMed ID: 12177374
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease.
Sergeant N; David JP; Champain D; Ghestem A; Wattez A; Delacourte A
J Neurochem; 2002 May; 81(4):663-72. PubMed ID: 12065626
[TBL] [Abstract][Full Text] [Related]
4. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
[TBL] [Abstract][Full Text] [Related]
5. Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases.
Bilousova T; Miller CA; Poon WW; Vinters HV; Corrada M; Kawas C; Hayden EY; Teplow DB; Glabe C; Albay R; Cole GM; Teng E; Gylys KH
Am J Pathol; 2016 Jan; 186(1):185-98. PubMed ID: 26718979
[TBL] [Abstract][Full Text] [Related]
6. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
7. Abeta deposition does not cause the aggregation of endogenous tau in transgenic mice.
Xu G; Gonzales V; Borchelt DR
Alzheimer Dis Assoc Disord; 2002; 16(3):196-201. PubMed ID: 12218652
[TBL] [Abstract][Full Text] [Related]
8. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
9. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.
Maia LF; Kaeser SA; Reichwald J; Hruscha M; Martus P; Staufenbiel M; Jucker M
Sci Transl Med; 2013 Jul; 5(194):194re2. PubMed ID: 23863834
[TBL] [Abstract][Full Text] [Related]
10. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
11. Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease.
Koss DJ; Dubini M; Buchanan H; Hull C; Platt B
Brain Res; 2018 Nov; 1699():121-134. PubMed ID: 30102892
[TBL] [Abstract][Full Text] [Related]
12. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
[TBL] [Abstract][Full Text] [Related]
13. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain.
Horie K; Barthélemy NR; Mallipeddi N; Li Y; Franklin EE; Perrin RJ; Bateman RJ; Sato C
Acta Neuropathol Commun; 2020 Aug; 8(1):149. PubMed ID: 32854776
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
[TBL] [Abstract][Full Text] [Related]
15. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
16. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
17. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
[TBL] [Abstract][Full Text] [Related]
18. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
[TBL] [Abstract][Full Text] [Related]
19. Blood-based Aβ42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention.
Botella Lucena P; Vanherle S; Lodder C; Gutiérrez de Ravé M; Stancu IC; Lambrichts I; Vangheluwe R; Bruffaerts R; Dewachter I
Acta Neuropathol; 2022 Sep; 144(3):489-508. PubMed ID: 35796870
[TBL] [Abstract][Full Text] [Related]
20. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Eisele YS; Duyckaerts C
Acta Neuropathol; 2016 Jan; 131(1):5-25. PubMed ID: 26715565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
